PRMA Consulting - Building a healthier Asia

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ Gelsolin, for the Treatment of ARDS

Thursday, January 26, 2023

BioAegis Therapeutics Inc a clinicalstage company developing therapies for inflammatory diseases through a portfolio built around plasma gelsolin a highly conserved and abundant endogenous human immune regulatory protein announces that the US Food an...

Centessa Pharmaceuticals Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of LB101, First LockBody® Candidate, for Solid Tumors

Thursday, January 26, 2023

Centessa Pharmaceuticals plc a clinicalstage pharmaceutical company that aims to discover and develop medicines that are transformational for patients today announced that it has received clearance of its Investigational New Drug IND application from...

TG Therapeutics Announces Commercial Launch of BRIUMVI™ (ublituximab-xiiy) for the Treatment of Adult Patients with Relapsing Forms of Multiple Sclerosis

Thursday, January 26, 2023

TG Therapeutics Inc announced the commercial launch of BRIUMVI ublituximabxiiy for the treatment of relapsing forms of multiple sclerosis RMS to include clinically isolated syndrome relapsingremitting disease and active secondary progressive disease...

Sona Nanotech to Acquire Cancer Therapy Developer Siva Therapeutics

Thursday, January 26, 2023

Sona Nanotech Inc is pleased to announce that it has entered into a binding agreement the Definitive Agreement on January to acquire Siva Therapeutics Inc Siva the developer of Targeted Hyperthermia Therapy THT photo thermal therapy for cancer tumo...

Lilly Supports Direct Relief's Efforts to Expand Access to Medicines by Improving Cold Chain Capacity

Thursday, January 26, 2023

Eli Lilly and Company and Direct Relief today announced a new initiative to expand access to medicines in low and middleincome countries by boosting cold chain capacity in countries Supported by M in funding from Lilly Direct Relief will purchase an...

Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer

Thursday, January 26, 2023

AstraZeneca and Daiichi Sankyos Enhertu trastuzumab deruxtecan has been approved in the European Union EU as monotherapy for the treatment of adult patients with unresectable or metastatic HERlow IHC or IHC ISH breast cancer who have received prior...

Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy

Wednesday, January 25, 2023

POXEL SA a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology including nonalcoholic steatohepatitis NASH and rare metabolic disorders today announced that European Co...

Innate Pharma announces HSR clearance regarding expansion of its collaboration with Sanofi on NK cell engagers

Wednesday, January 25, 2023

Innate Pharma SA announced today the expiration of the waiting period under the HartScottRodino HSR Antitrust Improvements Act of with respect to the previously announced expansion of its collaboration with Sanofi The licensing agreement is now effe...

AGC Biologics to Commercial Manufacture Provention Bio Diabetes Therapy

Tuesday, January 24, 2023

AGC Biologics a leading global Biopharmaceutical Contract Development and Manufacturing Organization CDMO today announced a new commercial manufacturing project at its Seattle protein biologics manufacturing site The CDMO is producing TZIELD teplizum...

Psyence and Eden Labs Announce Extraction and Product Development Collaboration

Tuesday, January 24, 2023

Psyence Group Inc a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing is pleased to announce that it has entered into a partnership with Eden Labs LLC Eden Labs a product development and extr...

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA SGS - ADVANCED ANALYTICS INTERPHEX 2023 Thermo Fisher Scientific - Gibco solutions ACG - Barrier Packaging